• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

OpenGate to buy Solvay subsidiaries in Europe and US

  • Harriet Matthews
  • Harriet Matthews
  • 06 January 2021
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

OpenGate Capital is to acquire Belgium-headquartered chemical company Solvay's European and US amphoteric surfactant operations.

The transaction is expected to close by the end of 2021, according to a statement. The deal remains subject to regulatory and works council approvals.

The deal comprises the operations in Illinois in the US, where the company will be headquartered, as well as sites in Germany and the UK, plus a tolling business in Turkey.

Solvay's European and US amphoteric surfactant operations

  • DEAL:

    Buyout

  • LOCATION:

    University Park

  • SECTOR:

    Speciality chemicals

  • STAFF:

    175

OpenGate intends to appoint John Foley as CEO of the business on completion of the transaction, the GP said in a statement. Foley has previously held chemical industry roles including as vice-president and general manager of Novecare North America, a division of Solvay.

In June 2020, Belgian publication De Tijd reported that Solvay's amphoteric surfactant operations was one of two business divisions being considered for a sale. The report stated that the unit contributes €10m to Solvay's yearly profit and could yield proceeds of €75m.

The second business division mentioned in the report, Solvay's strontium carbonate production unit, was sold to Latour Capital in November 2020.

OpenGate is currently deploying equity via OpenGate Capital Partners II, which held a final close in November 2019 on $585m. The fund focuses on lower-mid-market businesses in the US and Europe, investing in companies in the industrial, technology, consumer and business services sectors with enterprise values of up to $300m.

OpenGate acquired Belgium-based digital cutting systems manufacturer Kongsberg Precision Cutting Systems from Esko-Graphics in December 2020.

Company
Solvay's European and North American amphoteric surfactant operations are headqartered in University Park (Illinois), with additional sites in Genthin (Germany) and Halifax (UK), as well as a tolling business in Turkey. The company produces amphoterics for use in consumer goods such as body care, hair care and home care products. The company employs 175 people.

People
OpenGate Capital
– Andrew Nikou (founder, CEO).
Solvay – Michael Radossich (president of Solvay's Novecare global business unit).

Advisers
Equity
 – Morgan Lewis (legal); KPMG (financial due diligence); Alvarez & Marsal (tax); MDW Capital (debt advisory)

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • DACH
  • UK / Ireland
  • Industrials
  • United States
  • Germany
  • United Kingdom
  • Carve-out
  • OpenGate Capital

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013